Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Michel Marty, PierFranco Conte|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005

Cited by 1.6k